Home-tDCS Depression Trial
Depression
Key Facts
About Soterix Medical
Soterix Medical is a private, revenue-generating medical device company focused on the neuroscience and neuromodulation sector. Its core business is providing high-precision, research-grade hardware (e.g., tDCS, HD-tES, TMS, tFUS devices) and sophisticated neurotargeting software to academic, clinical, and research institutions globally. The company has built a comprehensive portfolio that spans from foundational 1x1 tDCS systems to cutting-edge platforms like Temporal Interference Stimulation for deep brain targets, alongside synergistic monitoring technologies like EEG and fNIRS. Its strategy involves supporting the scientific community with tools for clinical trials and human performance testing while developing user-friendly solutions for clinical treatment.
View full company profileTherapeutic Areas
Other Depression Drugs
| Drug | Company | Phase |
|---|---|---|
| Undisclosed Programs | johnson-and-johnson-innovative-medicine | Pipeline |
| Depression Clinical Trials | IMA Clinical Research | Not Applicable (Service) |
| Depression Study | Sun Valley Research Center | Not Disclosed |
| eTNS Platform | NeuroSigma | Unknown |
| ALM003 | Almatica Pharma | Phase 3 |
| ALM014 | Almatica Pharma | Pivotal BA/BE |
| NRCT-101SR | Neurocentria | Phase 2b/3 |
| Starstim for Depression | Neuroelectrics | Phase 1/2 |
| Depression Biomarkers | Paradise Genomics | Discovery |
| BPL-003 | AtaiBeckley | Phase 2 |
| VLS-01 | AtaiBeckley | Phase 2 |
| NC-2800 | Nippon Chemiphar | Phase 2a |